Bionano Genomics (NASDAQ: BNGO) GC lists 15,000 stock option shares
Rhea-AI Filing Summary
Bionano Genomics, Inc. insider Jonathan V. Dixon, the company’s General Counsel, holds a stock option classified as a derivative security. The option covers 15,000 shares of Common Stock at an exercise price of $1.1200 per share and expires on August 2, 2036.
The shares subject to this option vest 50% on each of the first and second anniversaries of the vesting commencement date, in each case subject to Mr. Dixon’s Continuous Service under the company’s 2018 Plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Dixon Jonathan V.
Role
General Counsel
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) F1 | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 15,000 shares (Direct)
Footnotes (1)
- F1. The shares subject to the option vest 50% of the total on each of the first and second anniversaries of the vesting commencement date, in each case subject to the Reporting Person's Continuous Service (as defined in the Company's 2018 Plan) through each applicable vesting date.
Key Figures
Underlying Shares: 15000.0000 shares
Exercise Price: $1.1200 per share
Expiration Date: 2036-08-02
+2 more
5 metrics
Underlying Shares
15000.0000 shares
Common Stock underlying reported stock option
Exercise Price
$1.1200 per share
Exercise price of Stock Option (Right to Buy)
Expiration Date
2036-08-02
Expiration of the reported stock option
Vesting Tranche 1
50% of option
Vests on first anniversary of vesting commencement date
Vesting Tranche 2
50% of option
Vests on second anniversary of vesting commencement date
Key Terms
Stock Option (Right to Buy), Continuous Service, vesting commencement date, 2018 Plan
4 terms
Stock Option (Right to Buy) financial
"Security titled "Stock Option (Right to Buy)" over common stock"
Continuous Service financial
"subject to the Reporting Person's Continuous Service under the 2018 Plan"
vesting commencement date financial
"vest 50% on each of the first and second anniversaries of the vesting commencement date"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
2018 Plan financial
"as defined in the Company's 2018 Plan governing the option terms"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider role does Jonathan V. Dixon hold at Bionano Genomics (BNGO)?
Jonathan V. Dixon is the General Counsel of Bionano Genomics, Inc. He is reported as an officer, not a director or 10% owner, and his disclosed beneficial ownership relates to an option over the company’s common stock.
What is the exercise price and expiration date of Jonathan Dixon’s BNGO stock option?
The stock option has an exercise price of $1.1200 per share and an expiration date of 2036-08-02. This defines the price at which he may purchase the underlying shares and the last date on which the option can be exercised.
How does Jonathan Dixon’s BNGO stock option vest over time?
The option vests in two equal tranches of 50% of the total shares each. Half vests on the first anniversary and half on the second anniversary of the vesting commencement date, subject to his Continuous Service under the company’s 2018 Plan.
Is Jonathan Dixon’s ownership in BNGO common stock direct or indirect?
The reported derivative position is held with direct ownership. The option is listed as a direct holding, with no indication of indirect ownership through entities such as trusts, LLCs, or family members in the disclosure.